Home › Prostate Cancer › Arizona
Prostate Cancer clinical trials in Arizona
42 studies for Prostate Cancer are looking for participants at sites in Arizona.
Cities in Arizona
Radiation Therapy With RapidPlan Knowledge-based Planning vs Human-Driven Planning for Treatment of Prostate Cancer
- Mayo Clinic in Arizona, Scottsdale
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 2, 2026 · NCT06625034Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Banner University Medical Center - Tucson, Tucson
- University of Arizona Cancer Center-North Campus, Tucson
RecruitingPhase 3
Ages 18 and older · Men · Updated Oct 2, 2026 · NCT06931340Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Kingman Regional Medical Center, Kingman
- Cancer Center at Saint Joseph's, Phoenix
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Banner University Medical Center - Tucson, Tucson
- University of Arizona Cancer Center-North Campus, Tucson
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06632977Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Mayo Clinic Hospital in Arizona, Phoenix
- Mayo Clinic in Arizona, Scottsdale
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT03866382Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- Mayo Clinic, Scottsdale
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 29, 2026 · NCT01492972DESTINY-PANTUMOUR04
- Research Site, Bullhead City
- Research Site, Casa Grande
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 25, 2026 · NCT07124000A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- The University of Arizona Cancer Center - North Campus ( Site 0073), Tucson
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06136650This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers, Chandler
- Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers, Gilbert
- Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers, Glendale
- and 5 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 24, 2026 · NCT07028853Androgen Deprivation Therapy (Relugolix) for the Improvement of Diagnostic Imaging (PSMA PET/CT Scan) in Patients With High Risk or Very High Risk Prostate Cancer, The EnrichPSMA Trial
- Mayo Clinic in Arizona, Scottsdale
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 23, 2026 · NCT07025369Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Honor Health Research Institute, Scottsdale
RecruitingPhase 2/3
Ages 18 to 100 · Men · Updated Sep 22, 2026 · NCT06780670A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- City of Hope Cancer Center Phoenix, Goodyear
- University of Arizona Cancer Center, Tucson
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 22, 2026 · NCT07213674A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Phoenix
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 18, 2026 · NCT06952803A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
- GSK Investigational Site, Phoenix
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Sep 18, 2026 · NCT06990880A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Mayo Clinic in Arizona - Phoenix ( Site 0044), Phoenix
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT06925737A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
- Academic Urology and Urogynecology of Arizona, Peoria
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 15, 2026 · NCT07332000Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Mayo Clinic, Scottsdale
Recruiting
Ages 18 and older · Men · Updated Sep 14, 2026 · NCT06511141Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Mayo Clinic- Phoenix, Phoenix
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 11, 2026 · NCT06056830A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
- HonorHealth, Scottsdale
RecruitingPhase 1
Ages 18 and older · Men · Updated Sep 8, 2026 · NCT05800665A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer
- Honor Health Research Institute, Scottsdale
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Sep 4, 2026 · NCT07567846AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Phoenix
RecruitingPhase 3
Ages 18 and older · Men · Updated Aug 26, 2026 · NCT07611110Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Cancer Center at Saint Joseph's, Phoenix
RecruitingPhase 3
Ages 18 and older · Men · Updated Aug 19, 2026 · NCT04423211A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Western Regional Medical Center - City of Hope Phoenix Goodyear, Goodyear
- HonorHealth Research Institute, Scottsdale
- The University of Arizona Cancer Center - North Campus, Tucson
RecruitingPhase 2
Ages 18 and older · Men · Updated Aug 17, 2026 · NCT06842498FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Mayo Clinic, Phoenix
- Honor Health, Scottsdale
- Arizona Cancer Center at University of Arizona, Tucson
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05919264Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Mayo Clinic, Phoenix
RecruitingPhase 1
Ages 18 to 100 · Men · Updated Aug 13, 2026 · NCT05519449Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
- Investigative Site #108, Goodyear
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT06545942PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
- Banner MD Anderson, Gilbert
RecruitingPhase 3
Ages 18 and older · Men · Updated Jul 22, 2026 · NCT06274047Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
- Mayo Clinic in Arizona, Phoenix
RecruitingPhase 2
Ages 18 and older · Men · Updated Jul 20, 2026 · NCT06378866Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Cancer Center at Saint Joseph's, Phoenix
RecruitingPhase 3
Ages 18 and older · Men · Updated Jul 14, 2026 · NCT06592924Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients
- Mayo Clinic in Arizona, Scottsdale
RecruitingEarly phase 1
Ages 18 and older · Men · Updated Jun 8, 2026 · NCT05045066A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
- Honor Health, Scottsdale
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Jun 4, 2026 · NCT06609005Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Mayo Clinic Arizona, Scottsdale
RecruitingPhase 4
Ages 18 to 100 · Men · Updated Jun 4, 2026 · NCT05803941A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Mayo Clinic, Phoenix
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Mar 27, 2026 · NCT06395519Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy
- Arizona Urology Specialists, Tucson
RecruitingPhase 1
Ages 18 and older · Men · Updated Feb 19, 2026 · NCT06450106A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- HonorHealth Research Institute, Scottsdale
- The University of Arizona Cancer Center, Tucson
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Feb 13, 2026 · NCT06778863Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
- Cancer Center at Saint Joseph's, Phoenix
RecruitingPhase 2
Ages 18 and older · Men · Updated Jan 29, 2026 · NCT05806515Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- Scottsdale Medical Imaging, LLC, Scottsdale
RecruitingPhase 4
Ages 18 to 64 · All sexes · Updated Jan 22, 2026 · NCT043735644-aminopyridine Treatment for Nerve Injury
- University of Arizona, Tucson
RecruitingPhase 2/3
Ages 45 to 75 · Men · Updated Dec 17, 2025 · NCT03701581A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 111, Tucson
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 21, 2025 · NCT05914116Understanding of Genetics by Men at Risk for Prostate Cancer
- Mayo Clinic, Phoenix
RecruitingHealthy volunteers welcome
Ages 40 to 95 · Men · Updated Nov 6, 2025 · NCT04550845From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.